Several biomarkers, including the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67 are routinely used to classify breast cancer subtypes in the clinic [3,4]. This evidence concerns the gene ESR1 and breast cancer.